Morphometric studies of the neuropathological changes in choreatic diseases
- PMID: 133209
- DOI: 10.1016/0022-510x(76)90114-3
Morphometric studies of the neuropathological changes in choreatic diseases
Abstract
The striatum, pallidum and subthalamic nucleus were studied by combined morphometric methods in serial sections of 13 brains of normal adults and of 15 patients with choreatic diseases. In addition the volume of the hemispheres and of the cortex were measured. All data obtained were corrected by the shrinkage factor to represent fresh brain values. In Huntington's chorea the pallidum was more severely affected than is commonly appreciated. The average volume reduction was of the same degree (lateral-57%, medial-50%) as that of the striatum (-56%). The absolute number of nerve cells of the pallidum decreased in both segments by about 40%. The reduction of the volume and of the number of nerve cells was not reduced in the three subcortical nuclei studied. For the first time it has been shown that there is no increase in the absolute number of glial cells in the striatum. The increased numerical density of glial cells is caused by shrinkage. The loss of nerve cells of the pallidum and subthalamic nucleus is caused mainly by a primary process. Huntington's chorea is a multifocal process. Morphometric data do not suggest that subchorea is a variant of Huntington's chorea. Chorea minor is regarded as a multifocal process with varying affliction of the striatum, pallidum and subthalamic nucleus. An increase in the number of glial cells and, as a rule, a moderate loss of nerve cells were found in this disease.
Similar articles
-
[Morphometrical-statistical structure analysis of human striatum, pallidus and subthalamic nucleus. II. Globus pallidus].J Hirnforsch. 1975;16(5):401-13. J Hirnforsch. 1975. PMID: 1214059 German.
-
[Morphometrical-statistical structure analysis of human striatum, pallidum and subthalamic nucleus].J Hirnforsch. 1975;16(4):333-50. J Hirnforsch. 1975. PMID: 1214057 German.
-
Selective vulnerability in Huntington's disease: preferential loss of cannabinoid receptors in lateral globus pallidus.Ann Neurol. 1994 Oct;36(4):577-84. doi: 10.1002/ana.410360406. Ann Neurol. 1994. PMID: 7944290
-
[Morphofunctional features of the substantia nigra, its role in brain pathology and the action of pharmacologic substances].Usp Fiziol Nauk. 1979 Apr-Jun;10(2):45-72. Usp Fiziol Nauk. 1979. PMID: 38580 Review. Russian. No abstract available.
-
Chapter 33: the history of movement disorders.Handb Clin Neurol. 2010;95:501-46. doi: 10.1016/S0072-9752(08)02133-7. Handb Clin Neurol. 2010. PMID: 19892136 Review.
Cited by
-
Role of hypokinesia and bradykinesia in gait disturbances in Huntington's disease: a biomechanical study.J Neurol. 2006 Jan;253(1):73-80. doi: 10.1007/s00415-005-0929-2. Epub 2005 Aug 17. J Neurol. 2006. PMID: 16096818
-
Topography of cerebral atrophy in early Huntington's disease: a voxel based morphometric MRI study.J Neurol Neurosurg Psychiatry. 2004 Feb;75(2):213-20. J Neurol Neurosurg Psychiatry. 2004. PMID: 14742591 Free PMC article.
-
Huntington's Disease and Striatal Signaling.Front Neuroanat. 2011 Aug 23;5:55. doi: 10.3389/fnana.2011.00055. eCollection 2011. Front Neuroanat. 2011. PMID: 22007160 Free PMC article.
-
Mouse models of human CAG repeat disorders.Brain Pathol. 1997 Jul;7(3):965-77. doi: 10.1111/j.1750-3639.1997.tb00896.x. Brain Pathol. 1997. PMID: 9217978 Free PMC article. Review.
-
The diencephalon in schizophrenia: evidence for reduced thickness of the periventricular grey matter.Eur Arch Psychiatry Neurol Sci. 1984;234(4):212-9. doi: 10.1007/BF00381351. Eur Arch Psychiatry Neurol Sci. 1984. PMID: 6526059
MeSH terms
LinkOut - more resources
Full Text Sources